Brief: Lumos Pharma Announces Retirement Of Carl Langren And Names Lori Lawley Chief Financial Officer In Planned Succession
20/04/2021 21:09
April 20 (Reuters) - Lumos Pharma Inc LUMO.O :
* LUMOS PHARMA ANNOUNCES RETIREMENT OF CARL LANGREN AND
NAMES LORI
LAWLEY CHIEF FINANCIAL OFFICER IN PLANNED SUCCESSION
* LUMOS PHARMA INC - LORI LAWLEY WILL SUCCEED LANGREN AS CFO
EFFECTIVE AS OF JULY 4, 2021
Source text for Eikon: ID:nGNX2F9sTK
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)